Published in J Cosmet Dermatol on September 01, 2008
Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions. BMC Immunol (2012) 0.80
Evaluating of life quality in patients with acne vulgaris using generic and specific questionnaires. Dermatol Res Pract (2013) 0.77
The Prevalence of Vitiligo: A Meta-Analysis. PLoS One (2016) 0.75
Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation. J Clin Aesthet Dermatol (2014) 0.75
Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging. Clin Cosmet Investig Dermatol (2015) 0.75
A Comparative Study of Two Modalities, 4% Hydroquinone Versus 30% Salicylic Acid in Periorbital Hyperpigmentation and Assessment of Quality of Life Before and After Treatment. Indian J Dermatol (2016) 0.75
Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation. J Clin Aesthet Dermatol (2015) 0.75
Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol (2008) 3.95
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88
Measuring patients' trust in their primary care providers. Med Care Res Rev (2002) 3.43
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol (2003) 3.22
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol (2009) 2.91
In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol (2002) 2.75
Trust in the medical profession: conceptual and measurement issues. Health Serv Res (2002) 2.46
The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol (2005) 2.26
Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol (2009) 2.14
Willing to wait?: the influence of patient wait time on satisfaction with primary care. BMC Health Serv Res (2007) 2.10
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol (2004) 2.05
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol (2011) 2.03
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol (2008) 1.99
Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94
Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol (2007) 1.76
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol (2009) 1.76
Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics (2010) 1.70
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Switching from prescription to over-the counter medications: a consumer and managed care perspective. Manag Care Interface (2007) 1.67
Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat (2006) 1.64
The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care (2005) 1.64
Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther (2004) 1.62
Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med (2004) 1.60
Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes (2010) 1.60
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol (2006) 1.59
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther (2007) 1.58
Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol (2010) 1.55
Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol (2010) 1.53
Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause (2010) 1.52
Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. Pediatr Crit Care Med (2009) 1.52
Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol (2008) 1.52
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol (2007) 1.51
A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol (2010) 1.50
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol (2007) 1.50
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol (2012) 1.49
UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol (2008) 1.48
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol (2009) 1.48
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol (2005) 1.45
Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol (2004) 1.45
Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol (2011) 1.44
Economic evaluation of carotid artery stenting versus carotid endarterectomy for the treatment of carotid artery stenosis. J Am Coll Surg (2007) 1.44
Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol (2006) 1.44
Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs (2004) 1.43
Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol (2003) 1.43
Dermatosis neglecta: a series of case reports and review of other dirty-appearing dermatoses. Dermatol Online J (2006) 1.42
Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg (2015) 1.42
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol (2005) 1.42
Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol (2006) 1.40
How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat (2006) 1.40
Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol (2006) 1.40
Where did current academic dermatologists train? J Am Acad Dermatol (2010) 1.39
Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg (2005) 1.39
Over-the-counter medication labels: are we ignoring the needs of blind consumers? Optometry (2004) 1.38
Phototherapy trends in dermatology. J Dermatolog Treat (2013) 1.38
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc (2013) 1.34
Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol (2007) 1.34
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol (2005) 1.34
Quality of life in patients with psoriasis. Health Qual Life Outcomes (2006) 1.31
Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol (2008) 1.28
Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. Ultrasound Med Biol (2006) 1.28
Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc (2006) 1.27
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis (2002) 1.27
The safety of liposuction: results of a national survey. Dermatol Surg (2002) 1.25
Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics (2009) 1.24
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22
Patient injuries from surgical procedures performed in medical offices: three years of Florida data. Dermatol Surg (2004) 1.20
The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw (2010) 1.20
The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol (2011) 1.19
Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache (2003) 1.19
A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures. Patient Prefer Adherence (2010) 1.19
Tanning as an addictive behavior: a literature review. Photodermatol Photoimmunol Photomed (2009) 1.19
Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol (2007) 1.19
Correlates of patient satisfaction with physician visit: differences between elderly and non-elderly survey respondents. Health Qual Life Outcomes (2007) 1.18
Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol (2004) 1.17
What specialties perform the most common outpatient cosmetic procedures in the United States? Dermatol Surg (2007) 1.17
Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol (2004) 1.16
Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol (2005) 1.16
Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol (2014) 1.15